Explore chapters and articles related to this topic
Rheological Profiles
Published in Laba Dennis, Rheological Proper ties of Cosmetics and Toiletries, 2017
Water, mineral oil, potassium stearate, sodium stearate, cholesterol, cetyl palmitate, sodium polyacrylate/ saccharide, castor oil, pantethine, sodium laurate, potassium laurate, sodium myristate, potassium myristate, myristyl alcohol, cetyl alcohol, sodium palmitate, potassium palmitate, stearyl alcohol, sodium carbomer, potassium carbomer, butylparaben, propylparaben, methylparaben, imidazolidinyl urea, fragrance, FD&C Red No. 4.
Polymer/Surfactant Interaction
Published in E. Desmond Goddard, James V. Gruber, Principles of Polymer Science and Technology in Cosmetics and Personal Care, 1999
E. Desmond Goddard, James V. Gruber
Figure 24 Viscosity of solutions of sodium polyacrylate and polyacrylate hydrophobically modified within and alkyl side groups, in combination with added DTAB (open symbols) and DTAC (filled symbols) surfactants. (From Ref. 90.)
Bowel obstruction following ingestion of superabsorbent polymers beads: literature review
Published in Clinical Toxicology, 2022
Weniko Caré, Laurène Dufayet, Nathalie Paret, Jacques Manel, Hervé Laborde-Casterot, Ingrid Blanc-Brisset, Jérôme Langrand, Dominique Vodovar
Most marketed superabsorbent polymer-made beads are cross-linked sodium polyacrylate. After ingestion of these beads, no systemic toxicity is expected, and no case of toxicity has been reported with exposure by the oral route in both humans and animals [4–9]. However, given the ability of these beads to swell in contact with a water-containing liquid, mechanical complications are to be expected, and cases of bowel obstruction following ingestion of these products have been reported [2,10]. Some superabsorbent polymer-made toys were withdrawn from the market in the United States in 2013. Then, the Australian Competition and Consumer Commission recommended that these beads should no longer be marketed as toys, and they launched an alert campaign on their risks in 2015 [11,12].
Improved transdermal permeability of tanshinone IIA from cataplasms by loading onto nanocrystals and porous silica
Published in Pharmaceutical Development and Technology, 2021
Xiangshuai Gu, Jueshuo Guo, Yaping Mai, Yang Niu, Jing Chen, Qipeng Zhao, Jianhong Yang
Tanshinone IIA (98% purity) was purchased from Shanxi Qingya Biotechnology Co., Ltd (Xian, China). Porous silica (SYLOID 244FP) was supplied by Grace GmbH &Co.KG (Germany). SDS was purchased from Xian Hengyi Biotechnology Co., Ltd.(Xian, China). HPMC-E5 was purchased from Ashland Chemical Co., Ltd.(Nanjing, China). Methanol and acetonitrile were purchased from Thermo Fisher Scientific Inc. (Beijing, China). Trichloromethane was purchased from Tianjin Damao Chemical Reagent Co., Ltd. (Tianjin, China). Sodium polyacrylate (X-305) was purchased from Toagosei (Toyko, Japan). Polyvinyl alcohol (PVA) was purchased from Jiangxi Alpha Gaoke Pharmaceutical Co., Ltd. (Jiangxi, China). Polyvinylpyrrolidone (K90) was purchased from Beijing Fengli Jingqiu Pharmaceutical Co., Ltd. (Beijing China). Glycerin was purchased from Hunan Erkang Pharmaceutical Co., Ltd. (Changsha, China). Aluminium glycinate was purchased from Cool Chemical Technology Co., Ltd. (Beijing, China). Tartaric acid was purchased from Chengdu Huasheng Pharmaceutical Excipient Manufacturing Co., Ltd. (Chengdu, China). Aluminum hydroxide was purchased from Guangdong Chemical Reagent Engineering-Technological Research and Development Center (Guangdong, China). Nile red was purchased from Cool Chemical Technology Co., Ltd. (Beijing, China). Vertical Franz-type diffusion cell was purchased from Shanghai Huanghai Drug testing instrument sales Co., Ltd. (Shanghai, China). PVC membrane (anti-adhesion layer) was purchased from Jiaxing Shengcai Printing Film Co., Ltd. (Zhejiang, China). Non-woven fabric (backing layer) was purchased from Guangzhou Shenggu Pharmaceutical Co., Ltd. (Guangdong, China). Tanshinone IIA reference substance was purchased from Ningxia Kangshu Technological Trading Co., Ltd. (Yinchuan, China).
Lessons learnt from early failure of a patient trial with a polymer-on-polymer resurfacing hip arthroplasty
Published in Acta Orthopaedica, 2018
Job L C Van Susante, Nico Verdonschot, L Paul A Bom, Pawel Tomaszewski, Pat Campbell, Edward Ebramzadeh, B Wim Schreurs
Inclusion criteria were patients aged >18 years and severe osteoarthritis of the hip with normal anatomy of the joint. Patients with a potential allergy to polyether urethane, sodium polyacrylate, bone cement, or any of its components were excluded by means of a preoperative questionnaire.